Leucadia Therapeutics
Leucadia Therapeutics is dedicated to developing innovative treatments for Alzheimer's disease, focusing on restoring cerebrospinal fluid flow to prevent and cure the disease. Their mission is to end Alzheimer's through novel, non-invasive therapies and diagnostic tools, aiming to diagnose early, prevent, and reverse the disease.
Industries
Nr. of Employees
small (1-50)
Leucadia Therapeutics
Products
Implantable device to restore CSF flow across the cribriform plate
A small implantable device designed for outpatient placement in the cribriform plate to reestablish CSF egress, with the goal of improving clearance of toxic metabolites from brain regions implicated in early Alzheimer’s disease and treating mild cognitive impairment.
Proprietary cognitive assessment battery
A set of cognitive tests developed for use in clinical studies to assess memory and cognition and to support risk prediction for Alzheimer’s disease.
Implantable device to restore CSF flow across the cribriform plate
A small implantable device designed for outpatient placement in the cribriform plate to reestablish CSF egress, with the goal of improving clearance of toxic metabolites from brain regions implicated in early Alzheimer’s disease and treating mild cognitive impairment.
Proprietary cognitive assessment battery
A set of cognitive tests developed for use in clinical studies to assess memory and cognition and to support risk prediction for Alzheimer’s disease.
Services
Project Cribrose — clinical study for diagnostic refinement
A large observational study combining a short CT scan and a battery of cognitive tests to refine proprietary diagnostic tools for assessing Alzheimer’s disease risk; includes clinical recruitment and collaboration with neurosurgical partners.
Clinical collaboration and device implantation support
Collaboration with neurosurgeons and clinical centers to perform outpatient implantation procedures of the CSF drain device and to support clinical evaluation and follow-up.
Project Cribrose — clinical study for diagnostic refinement
A large observational study combining a short CT scan and a battery of cognitive tests to refine proprietary diagnostic tools for assessing Alzheimer’s disease risk; includes clinical recruitment and collaboration with neurosurgical partners.
Clinical collaboration and device implantation support
Collaboration with neurosurgeons and clinical centers to perform outpatient implantation procedures of the CSF drain device and to support clinical evaluation and follow-up.
Expertise Areas
- Implantable neurosurgical devices and outpatient implantation procedures
- CSF physiology and cribriform plate pathology
- Diagnostic development and biomarker validation for neurodegenerative disease
- Cognitive assessment development and digital cognitive testing
Key Technologies
- CT imaging for structural assessment
- Implantable CSF drainage devices
- Cognitive assessment batteries
- Outpatient neurosurgical implantation procedures